Tag: hepatocellular carcinoma immunotherapy

A retrospective study of 45 hepatocellular carcinoma patients found that intratumoral tertiary lymphoid structures were associated with disease control and ...

A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity ...

A new review explains how tumor ablation triggers a transient immune response in liver cancer and why combining it with ...

A case report details how HBsAg-targeted TCR-engineered T cells produced a manageable grade 3 cytokine release syndrome and a transient ...

In the relentless battle against hepatocellular carcinoma (HCC), one of the deadliest and most insidious forms of liver cancer, recent ...

Recent research conducted by Meng, Nian, Feng, and colleagues has unveiled significant insights into the interaction between macrophages and natural ...

In the ever-evolving landscape of cancer research, a groundbreaking discovery has emerged from a recent study that sheds light on ...

Emerging research published in Genes & Immunity unveils a groundbreaking prognostic signature based on post-translational acylation modifications, illuminating new frontiers ...

A groundbreaking multinational study has shed new light on immune-mediated adverse events (irAEs) associated with the combination therapy of atezolizumab ...

In a transformative leap for cancer immunotherapy, researchers at Ludwig Cancer Research, led by Ping-Chih Ho and Yi-Ru Yu from ...